Here are four notes:
1. EndoChoice currently has a consensus rating of “buy” and an average target price of $16.31.
2. The company has a one-year low of $3.70 and a one-year high of $19.69.
3. The firm has a 50-day moving average of $5.03 and a 200-day moving average of $9.44.
4. EndoChoice’s market capitalization is $117.28 million.
More articles on GI/endoscopy:
GI physician leader to know: Dr. Neena Abraham of Mayo Clinic
5 most read GI/endoscopy stories: Week of Feb. 29 – March 4
St. Francis Regional, Ridgeview medical centers come together for GI care: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
